The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort


Radın M., Sciascia S., Erkan D., Pengo V., Tektonıdou M. G., Ugarte A., ...More

SEMINARS IN ARTHRITIS AND RHEUMATISM, vol.49, pp.464-468, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 49
  • Publication Date: 2019
  • Doi Number: 10.1016/j.semarthrit.2019.04.009
  • Journal Name: SEMINARS IN ARTHRITIS AND RHEUMATISM
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.464-468
  • Keywords: Antiphospholipid syndrome, Antiphospholipid antibodies, GAPSS, Thrombosis, Risk stratification, Cardiovascular, GUIDELINES, DIAGNOSIS, CRITERIA, UPDATE
  • Istanbul University Affiliated: Yes

Abstract

Objectives: To assess whether patients with antiphospholipid syndrome (APS) and history of recurrent thrombosis have higher levels of adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) when compared to patients without recurrent thrombosis.